AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
GH Research Maintains Strong Buy Rating with $40 Price Target from H.C. Wainwright
ByAinvest
Thursday, Aug 21, 2025 3:48 am ET1min read
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on GH Research (GHRS) with a price target of $40.00. Trucchio has an average return of 7.6% and a 42.68% success rate on recommended stocks. GH Research has a consensus rating of Strong Buy and a price target consensus of $32.86. The company has a one-year high of $20.50 and a one-year low of $6.00.
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on GH Research (GHRS) with a price target of $40.00. Trucchio, known for his strong track record with an average return of 7.6% and a 42.68% success rate on recommended stocks, remains bullish on GHRS [1].GH Research, which operates in the medical technology sector, has a consensus rating of Strong Buy among analysts, with a price target consensus of $32.86. This consensus rating is based on the average of 8 analysts' ratings over the past 3 months, with 8 analysts rating GHRS as a Strong Buy, and none rating it as Hold or Sell [2].
The company's stock has seen significant volatility over the past year, with a one-year high of $20.50 and a one-year low of $6.00. Despite this volatility, analysts remain optimistic about the company's future prospects. The average price target of $32.86 represents a potential 159.35% upside from the current price of $12.67, indicating strong growth expectations [2].
Analysts cite promising developments in GH Research's therapeutic research and development (TRD) program, as well as regulatory progress, as key drivers for their positive outlook. The company's strategic progress and financial stability have also been noted as positive factors [2].
Investors should closely monitor GH Research's developments and remain informed about the company's progress in its clinical trials and regulatory filings. The consensus rating and price targets provide a valuable insight into the market's expectations for GH Research's future performance.
References:
[1] https://www.marketbeat.com/stocks/NASDAQ/GHRS/forecast/
[2] https://www.tipranks.com/stocks/ghrs/forecast
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet